MarketCap
BioDelivery Sciences International BDSI
Facebook
X
Telegram
BioDelivery Sciences International Operating Cycle | BDSI
Annual Operating Cycle BioDelivery Sciences International
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 436 | 314 | 227 | 360 | 261 | 349 | 131 | 493 | 53.3 | 2.08 | 41.1 | 33.9 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 493 | 2.08 | 225 |
Quarterly Operating Cycle BioDelivery Sciences International
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 422 | 491 | 377 | 99.5 | 417 | 390 | 316 | 112 | 310 | 329 | 309 | 69 | 218 | 210 | 245 | 64.6 | 197 | 226 | 94.7 | 75.9 | 224 | 140 | 197 | 7.05 | 321 | 220 | 198 | 113 | 517 | 263 | 128 | 64.2 | 85.1 | 92.2 | 93.2 | 2.39 | 25.3 | 2.92 | 1.72 | - | 3.46 | 240 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 517 | 1.72 | 193 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
PolarityTE
PTE
|
219 | - | -0.82 % | $ 1.78 M |  USA |
 |
United Therapeutics Corporation
UTHR
|
198 | $ 595.86 | 1.23 % | $ 26.4 B | USA |
 |
Vericel Corporation
VCEL
|
187 | $ 59.45 | 0.7 % | $ 2.99 B | USA |
 |
Veracyte
VCYT
|
57.4 | $ 25.08 | 4.24 % | $ 1.97 B | USA |
 |
Advaxis
ADXS
|
3.28 K | - | -9.65 % | $ 45.9 M | USA |
 |
Trevena
TRVN
|
99 | - | -46.58 % | $ 31.8 M | USA |
 |
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | USA |
 |
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.42 | -0.15 % | $ 577 M |  Singapore |
 |
Exicure
XCUR
|
-4.16 | $ 1.05 | -2.78 % | $ 6.61 M | USA |
 |
Xeris Pharmaceuticals
XERS
|
558 | $ 16.51 | 4.3 % | $ 2.65 B | USA |
 |
Molecular Templates
MTEM
|
4.53 | - | -23.43 % | $ 495 K | USA |
 |
22nd Century Group
XXII
|
169 | $ 1.57 | 10.56 % | $ 289 K | USA |
 |
Zai Lab Limited
ZLAB
|
186 | $ 26.42 | -0.04 % | $ 28.9 B |  China |
 |
Zoetis
ZTS
|
380 | $ 82.56 | 0.12 % | $ 36.6 B | USA |
 |
BioXcel Therapeutics
BTAI
|
1.66 K | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
54.7 K | - | -2.99 % | $ 2.47 M | USA |
 |
Insmed Incorporated
INSM
|
400 | $ 120.63 | 0.95 % | $ 24 B | USA |
 |
Novan
NOVN
|
234 | - | -24.84 % | $ 2.64 M | USA |
 |
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | USA |
 |
bluebird bio
BLUE
|
180 | - | - | $ 546 M | USA |
 |
Intra-Cellular Therapies
ITCI
|
257 | - | - | $ 13.6 B | USA |
 |
Marinus Pharmaceuticals
MRNS
|
59.8 | - | - | $ 29.6 M | USA |
 |
NeuBase Therapeutics
NBSE
|
-65.8 | - | -1.56 % | $ 12.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
189 | - | - | $ 35.4 M | USA |
 |
Sigilon Therapeutics
SGTX
|
31.4 | - | - | $ 728 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Revance Therapeutics
RVNC
|
30.4 | - | - | $ 309 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
492 | $ 4.86 | 1.04 % | $ 787 M | USA |